|
|
|
Volumn 5, Issue 5, 1999, Pages 269-274
|
|
A survey of treatments used in patients with metastatic melanoma: Analysis of 189 patients referred to the National Cancer Institute
|
|
Author keywords
Chemotherapy; Clinical protocol; Melanoma; Metastatic disease; Systemic treatment
|
|
Indexed keywords
1 CHLORO 2,4 DINITROBENZENE;
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
BCG VACCINE;
CAMPTOTHECIN;
CANCER VACCINE;
CARBOPLATIN;
CARMUSTINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DACTINOMYCIN;
ETOPOSIDE;
FLUOROURACIL;
IFOSFAMIDE;
INTERLEUKIN 2;
INTERLEUKIN 6;
LEVAMISOLE;
MELPHALAN;
METHOTREXATE;
MONOCLONAL ANTIBODY;
NAVELBINE;
PACLITAXEL;
PROCARBAZINE;
TAMOXIFEN;
TUMOR NECROSIS FACTOR;
UNINDEXED DRUG;
VINBLASTINE;
ADULT;
AGED;
ARTICLE;
CANCER CENTER;
CANCER IMMUNOTHERAPY;
CANCER INCIDENCE;
CLINICAL PROTOCOL;
COST OF ILLNESS;
DIAGNOSTIC IMAGING;
DRUG COST;
DRUG EFFICACY;
FEMALE;
HUMAN;
MALE;
MELANOMA;
METASTASIS;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TUMOR BIOPSY;
UNITED STATES;
ADULT;
AGED;
AGED, 80 AND OVER;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
MALE;
MELANOMA;
MIDDLE AGED;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEOPLASM METASTASIS;
PROSPECTIVE STUDIES;
SKIN NEOPLASMS;
UNITED STATES;
|
|
EID: 0032819854
PISSN: 10814442
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (12)
|
